Found: 68
Select item for more details and to access through your institution.
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 623, doi. 10.1002/ajh.25796
- By:
- Publication type:
- Article
Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E150, doi. 10.1002/ajh.25447
- By:
- Publication type:
- Article
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0191461
- By:
- Publication type:
- Article
Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplification.
- Published in:
- Genes, Chromosomes & Cancer, 1990, v. 1, n. 4, p. 289, doi. 10.1002/gcc.2870010406
- By:
- Publication type:
- Article
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction.
- Published in:
- Genes, Chromosomes & Cancer, 1990, v. 1, n. 3, p. 228, doi. 10.1002/gcc.2870010307
- By:
- Publication type:
- Article
Leukemic differentiation of a mediastinal germ cell tumor.
- Published in:
- Genes, Chromosomes & Cancer, 1989, v. 1, n. 1, p. 83, doi. 10.1002/gcc.2870010113
- By:
- Publication type:
- Article
Mechanism of Fas Signaling Regulation by Human Herpesvirus 8 K1 Oncoprotein.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 6, p. 399, doi. 10.1093/jnci/djn516
- By:
- Publication type:
- Article
Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene.
- Published in:
- 2002
- By:
- Publication type:
- journal article
IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstrates Marked Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (iNHL): Results from the Phase 2 Global UNITY-NHL Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S404, doi. 10.1016/S2152-2650(21)01912-1
- By:
- Publication type:
- Article
Poster: IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstrates Marked Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (iNHL): Results from the Phase 2 Global UNITY-NHL Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01537-8
- By:
- Publication type:
- Article
Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 15, doi. 10.1016/j.clml.2012.09.009
- By:
- Publication type:
- Article
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 2, p. 284, doi. 10.1111/j.1365-2141.2011.08618.x
- By:
- Publication type:
- Article
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 200, doi. 10.1111/j.1365-2141.2010.08228.x
- By:
- Publication type:
- Article
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 3, p. 355, doi. 10.1111/j.1365-2141.2008.07353.x
- By:
- Publication type:
- Article
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 4, p. 502, doi. 10.1111/j.1365-2141.2007.06684.x
- By:
- Publication type:
- Article
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 3, p. 439, doi. 10.1111/j.1365-2141.2006.06457.x
- By:
- Publication type:
- Article
Artroplastia unicompartimental de rodilla con prótesis "Oxford.".
- Published in:
- Acta Ortopédica Mexicana, 2007, v. 21, n. 2, p. 49
- By:
- Publication type:
- Article
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 549, doi. 10.1634/theoncologist.2016-0328
- By:
- Publication type:
- Article
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 876, doi. 10.1002/cncr.35114
- By:
- Publication type:
- Article
Lenalidomide plus rituximab (R<sup>2</sup>) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 874, doi. 10.1111/bjh.15843
- By:
- Publication type:
- Article
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
- By:
- Publication type:
- Article
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R- FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 263, doi. 10.1111/bjh.14541
- By:
- Publication type:
- Article
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
- By:
- Publication type:
- Article
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 290, doi. 10.1111/bjh.14237
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 463, doi. 10.1111/bjh.13603
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 177, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 112, doi. 10.1111/bjh.12715
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Long term results of a phase 2 study of vincristine sulfate liposome injection ( Marqibo<sup>®</sup>) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non- Hodgkin lymphomas
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 631, doi. 10.1111/bjh.12446
- By:
- Publication type:
- Article
Urinary proteins with pro-apoptotic and antitumor activity.
- Published in:
- Apoptosis, 2000, v. 5, n. 1, p. 21, doi. 10.1023/A:1009629424297
- By:
- Publication type:
- Article
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 4, p. 1023, doi. 10.1002/cncr.26360
- By:
- Publication type:
- Article
Phase 2 Study of Gemcitabine in Combination With Rituximab in Patients With Recurrent or Refractory Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 4, p. 831, doi. 10.1002/cncr.23237
- By:
- Publication type:
- Article
The oncologic burden of hepatitis C virus infection: A clinical perspective.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice